{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:07:57Z","timestamp":1785607677169,"version":"3.56.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12033-024-01358-5","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:49:04Z","timestamp":1736426944000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4486-3097","authenticated-orcid":false,"given":"Kanwal","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng-Kai","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"1358_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jhin.2020.07.009","volume":"106","author":"KH Chan","year":"2020","unstructured":"Chan, K. H., Sridhar, S., Zhang, R. R., Chu, H., Fung, A. Y. F., Chan, G., Chan, J. F. W., To, K. K. W., Hung, I. F. N., Cheng, V. C. C., & Yuen, K. Y. (2020). Factors affecting stability and infectivity of SARS-CoV-2. Journal of Hospital Infection, 106, 226\u2013231.","journal-title":"Journal of Hospital Infection"},{"key":"1358_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","volume":"41","author":"AG Harrison","year":"2020","unstructured":"Harrison, A. G., Lin, T., & Wang, P. (2020). Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends in Immunology, 41, 1100\u20131115.","journal-title":"Trends in Immunology"},{"key":"1358_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2666-5247(23)00133-7","volume":"4","author":"T Burki","year":"2023","unstructured":"Burki, T. (2023). First shared SARS-CoV-2 genome: GISAID vs virological.org. The Lancet Microbe., 4, 395.","journal-title":"The Lancet Microbe."},{"key":"1358_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12931-020-01581-z","volume":"21","author":"M Rastogi","year":"2020","unstructured":"Rastogi, M., Pandey, N., Shukla, A., & Singh, S. K. (2020). SARS coronavirus 2: From genome to infectome. Respiratory Research, 21, 318.","journal-title":"Respiratory Research"},{"key":"1358_CR5","first-page":"172","volume":"28","author":"M Ashraf","year":"2021","unstructured":"Ashraf, M., Sharif, S., Ahmad, M., Zahid, M., & Mukhtar, H. (2021). A review on clinical, pathological characteristics and drug designing for COVID-19. Arab J Basic Appl Sci., 28, 172\u2013186.","journal-title":"Arab J Basic Appl Sci."},{"key":"1358_CR6","unstructured":"Puranik, A., Lenehan, P. J., Silvert, E., Niesen, M. J. M., Corchado-Garcia, J., O\u2019Horo, J. C., Virk, A., Swift, M. D., Halamka, J., Badley, A. D., Venkatakrishnan, A. J. and Soundararajan, V. (2021) medRxiv : the preprint server for health sciences."},{"key":"1358_CR7","doi-asserted-by":"crossref","unstructured":"Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., Duncan, \u2026 Zuidewind, P. (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 397, 99\u2013111.","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"1358_CR8","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1186\/s12889-022-14016-9","volume":"22","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Belayachi, J., Yang, Y., Fu, Q., Rodewald, L., Li, H., Yan, B., Wang, Y., Shen, Y., Yang, Q., Mu, W., Tang, R., Su, C., Xu, T., Obtel, M., Mhayi, A., Razine, R., Abouqal, R., Zhang, Y., & Yang, X. (2022). Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco. BMC Public Health, 22, 1584.","journal-title":"BMC Public Health"},{"key":"1358_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000003","volume":"16","author":"S Duffy","year":"2018","unstructured":"Duffy, S. (2018). Why are RNA virus mutation rates so damn high? PLoS Biology, 16, e3000003.","journal-title":"PLoS Biology"},{"key":"1358_CR10","first-page":"204993612110243","volume":"8","author":"A Sanyaolu","year":"2021","unstructured":"Sanyaolu, A., Okorie, C., Marinkovic, A., Haider, N., Abbasi, A. F., Jaferi, U., Prakash, S., & Balendra, V. (2021). The emerging SARS-CoV-2 variants of concern. Ther Adv Infect Dis., 8, 20499361211024372.","journal-title":"Ther Adv Infect Dis."},{"key":"1358_CR11","first-page":"1303","volume":"9","author":"AY-K Thye","year":"2021","unstructured":"Thye, A.Y.-K., Law, J.W.-F., Pusparajah, P., Letchumanan, V., Chan, K.-G., & Lee, L.-H. (2021). Psychological symptoms in COVID-19 patients: Insights into pathophysiology and risk factors of long COVID-19. Biology., 9, 1303.","journal-title":"Biology."},{"key":"1358_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198141","volume":"288","author":"SK Samrat","year":"2020","unstructured":"Samrat, S. K., Tharappel, A. M., Li, Z., & Li, H. (2020). Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Virus Research, 288, 198141.","journal-title":"Virus Research"},{"key":"1358_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","volume":"593","author":"DA Collier","year":"2021","unstructured":"Collier, D. A., De Marco, A., Ferreira, I. A., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., & Silacci-Fregni, C. (2021). Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies. Nature, 593, 136\u2013141.","journal-title":"Nature"},{"key":"1358_CR14","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","volume":"384","author":"SA Madhi","year":"2021","unstructured":"Madhi, S. A., Baillie, V., Cutland, C. L., Voysey, M., Koen, A. L., Fairlie, L., Padayachee, S. D., Dheda, K., Barnabas, S. L., & Bhorat, Q. E. (2021). Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. NEJM, 384, 1885\u20131898.","journal-title":"NEJM"},{"key":"1358_CR15","unstructured":"Wu, K., Werner, A. P., Moliva, J. I., Koch, M., Choi, A., Stewart-Jones, G. B., Bennett, H., Boyoglu-Barnum, S., Shi, W. and Graham, B. S. (2021) bioRxiv : the preprint server for biology, 2021.2001. 2025.427948."},{"key":"1358_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2022","unstructured":"Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., & Amoako, D. G. (2022). Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature, 602, 654\u2013656.","journal-title":"Nature"},{"key":"1358_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41591-022-01704-7","volume":"28","author":"SM Cheng","year":"2022","unstructured":"Cheng, S. M., Mok, C. K. P., Leung, Y. W., Ng, S. S., Chan, K. C., Ko, F. W., Chen, C., Yiu, K., Lam, B. H., & Lau, E. H. (2022). Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA. 1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nature Medicine, 28, 486\u2013489.","journal-title":"Nature Medicine"},{"key":"1358_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41392-021-00623-2","volume":"6","author":"JY Noh","year":"2021","unstructured":"Noh, J. Y., Jeong, H. W., & Shin, E.-C. (2021). SARS-CoV-2 mutations, vaccines, and immunity: Implication of variants of concern. Signal Transduction and Targeted Therapy, 6, 203.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1358_CR19","unstructured":"WHO (2024) WHO COVID-19 dashboard."},{"key":"1358_CR20","doi-asserted-by":"publisher","first-page":"R918","DOI":"10.1016\/j.cub.2021.06.049","volume":"31","author":"SP Otto","year":"2021","unstructured":"Otto, S. P., Day, T., Arino, J., Colijn, C., Dushoff, J., Li, M., Mechai, S., Van Domselaar, G., Wu, J., & Earn, D. J. (2021). The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Current Biology, 31, R918\u2013R929.","journal-title":"Current Biology"},{"key":"1358_CR21","unstructured":"Chalkias, S., Whatley, J., Eder, F., Essink, B., Khetan, S., Bradley, P., Brosz, A., McGhee, N., Tomassini, J. E. and Chen, X. (2022) medRxiv : the preprint server for health sciences."},{"key":"1358_CR22","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.3390\/cells10112949","volume":"10","author":"JK Chaudhary","year":"2021","unstructured":"Chaudhary, J. K., Yadav, R., Chaudhary, P. K., Maurya, A., Kant, N., Rugaie, O. A., Haokip, H. R., Yadav, D., Roshan, R., & Prasad, R. (2021). Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity. Cells, 10, 2949.","journal-title":"Cells"},{"key":"1358_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40249-020-00713-3","volume":"9","author":"H-Z Chen","year":"2020","unstructured":"Chen, H.-Z., Tang, L.-L., Yu, X.-L., Zhou, J., Chang, Y.-F., & Wu, X. (2020). Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Infectious Diseases of Poverty, 9, 88.","journal-title":"Infectious Diseases of Poverty"},{"key":"1358_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/bib\/bbz051","volume":"21","author":"S Mei","year":"2020","unstructured":"Mei, S., Li, F., Leier, A., Marquez-Lago, T. T., Giam, K., Croft, N. P., Akutsu, T., Smith, A. I., Li, J., & Rossjohn, J. (2020). A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction. Briefings in Bioinformatics, 21, 1119\u20131135.","journal-title":"Briefings in Bioinformatics"},{"key":"1358_CR25","volume":"6","author":"M Hellerstein","year":"2020","unstructured":"Hellerstein, M. (2020). What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? Vaccine., 6, 100076.","journal-title":"Vaccine."},{"key":"1358_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/B978-0-12-809633-8.20248-3","volume-title":"Encyclopedia of bioinformatics and computational biology","author":"R Kogay","year":"2019","unstructured":"Kogay, R., & Sch\u00f6nbach, C. (2019). Epitope predictions. In S. Ranganathan, M. Gribskov, K. Nakai, & C. Sch\u00f6nbach (Eds.), Encyclopedia of bioinformatics and computational biology (pp. 952\u2013971). Academic Press."},{"key":"1358_CR27","doi-asserted-by":"publisher","first-page":"2680160","DOI":"10.1155\/2017\/2680160","volume":"2017","author":"JL Sanchez-Trincado","year":"2017","unstructured":"Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017). Fundamentals and methods for T- and B-cell epitope prediction. Journal of Immunology Research, 2017, 2680160.","journal-title":"Journal of Immunology Research"},{"key":"1358_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41423-023-01095-w","volume":"21","author":"D Lapuente","year":"2024","unstructured":"Lapuente, D., Winkler, T. H., & Tenbusch, M. (2024). B-cell and antibody responses to SARS-CoV-2: Infection, vaccination, and hybrid immunity. Cellular & Molecular Immunology, 21, 144\u2013158.","journal-title":"Cellular & Molecular Immunology"},{"key":"1358_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101418","volume":"50","author":"J Sidney","year":"2020","unstructured":"Sidney, J., Peters, B., & Sette, A. (2020). Epitope prediction and identification- adaptive T cell responses in humans. Seminars in Immunology, 50, 101418.","journal-title":"Seminars in Immunology"},{"key":"1358_CR30","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1038\/s41467-023-42430-z","volume":"14","author":"C Choy","year":"2023","unstructured":"Choy, C., Chen, J., Li, J., Gallagher, D. T., Lu, J., Wu, D., Zou, A., Hemani, H., Baptiste, B. A., Wichmann, E., Yang, Q., Ciffelo, J., Yin, R., McKelvy, J., Melvin, D., Wallace, T., Dunn, C., Nguyen, C., Chia, C. W., \u2026 Weng, N. P. (2023). SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors. Nature Communications, 14, 6725.","journal-title":"Nature Communications"},{"key":"1358_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.570018","volume":"11","author":"I Khatri","year":"2020","unstructured":"Khatri, I., Staal, F. J. T., & van Dongen, J. J. M. (2020). Blocking of the high-affinity interaction-synapse between SARS-CoV-2 Spike and human ACE2 proteins likely requires multiple high-affinity antibodies: An immune perspective. Frontiers in Immunology, 11, 570018.","journal-title":"Frontiers in Immunology"},{"key":"1358_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/00063030-200721030-00002","volume":"21","author":"JM Gershoni","year":"2007","unstructured":"Gershoni, J. M., Roitburd-Berman, A., Siman-Tov, D. D., Freund, N. T., & Weiss, Y. (2007). Epitope Mapping epitopes. BioDrugs, 21, 145\u2013156.","journal-title":"BioDrugs"},{"key":"1358_CR33","doi-asserted-by":"crossref","unstructured":"Ayariga, J. A., Gildea, L., Ipimoroti, A. and Matthews, Q. L. (2021) Gp120 alters its conformation to enhance evasiveness and infectivity. SSRN.","DOI":"10.20944\/preprints202110.0344.v1"},{"key":"1358_CR34","doi-asserted-by":"crossref","unstructured":"Maoz-Segal, R. and Andrade, P. (2015) Molecular Mimicry and Autoimmunity, in Infection and Autoimmunity, pp. 27\u201344.","DOI":"10.1016\/B978-0-444-63269-2.00054-4"},{"key":"1358_CR35","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","volume":"166","author":"VC Huber","year":"2001","unstructured":"Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001). Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. The Journal of Immunology, 166, 7381\u20137388.","journal-title":"The Journal of Immunology"},{"key":"1358_CR36","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/vaccines11071264","volume":"11","author":"K Khalid","year":"2023","unstructured":"Khalid, K., & Poh, C. L. (2023). The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria. Vaccines., 11, 1264.","journal-title":"Vaccines."},{"key":"1358_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.advms.2023.05.003","volume":"68","author":"K Khalid","year":"2023","unstructured":"Khalid, K., & Poh, C. L. (2023). The development of DNA vaccines against SARS-CoV-2. Advances in Medical Sciences, 68, 213\u2013226.","journal-title":"Advances in Medical Sciences"},{"key":"1358_CR38","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/v15030624","volume":"15","author":"AA Al-Fattah Yahaya","year":"2023","unstructured":"Al-Fattah Yahaya, A. A., Khalid, K., Lim, H. X., & Poh, C. L. (2023). Development of next generation vaccines against SARS-CoV-2 and variants of concern. Viruses, 15, 624.","journal-title":"Viruses"},{"key":"1358_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vacrep.2016.07.002","volume":"6","author":"TA Ahmad","year":"2016","unstructured":"Ahmad, T. A., Eweida, A. E., & El-Sayed, L. H. (2016). T-cell epitope mapping for the design of powerful vaccines. Vaccine Rep., 6, 13\u201322.","journal-title":"Vaccine Rep."},{"key":"1358_CR40","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1080\/22221751.2021.1978823","volume":"10","author":"B Aparicio","year":"2021","unstructured":"Aparicio, B., & Casares, N. (2021). Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses. Emerg Microbes Infect., 10, 1931\u20131946.","journal-title":"Emerg Microbes Infect."},{"key":"1358_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.addr.2021.01.007","volume":"171","author":"MS Sohail","year":"2021","unstructured":"Sohail, M. S., Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2021). In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives. Advanced Drug Delivery Reviews, 171, 29\u201347.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"1358_CR42","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.3390\/cimb45100502","volume":"45","author":"N Erez","year":"2023","unstructured":"Erez, N., Achdout, H., Yahalom-Ronen, Y., Adutler-Lieber, S., Bar-On, L., Bar-Haim, E., Politi, B., Vitner, E. B., Tamir, H., Melamed, S., Paran, N., & Israely, T. (2023). Identification of T-Cell epitopes using a combined in-silico and experimental approach in a mouse model for SARS-CoV-2. Current Issues in Molecular Biology, 45, 7944\u20137955.","journal-title":"Current Issues in Molecular Biology"},{"key":"1358_CR43","first-page":"1","volume-title":"Fullerens, Graphenes and Nanotubes","author":"S Skariyachan","year":"2018","unstructured":"Skariyachan, S., & Garka, S. (2018). Chapter 1 - Exploring the binding potential of carbon nanotubes and fullerene towards major drug targets of multidrug resistant bacterial pathogens and their utility as novel therapeutic agents. In A. M. Grumezescu (Ed.), Fullerens, Graphenes and Nanotubes (pp. 1\u201329). William Andrew Publishing."},{"key":"1358_CR44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/vaccines11020399","volume":"11","author":"R Umitaibatin","year":"2023","unstructured":"Umitaibatin, R., Harisna, A. H., & Jauhar, M. M. (2023). Immunoinformatics study: Multi-epitope based vaccine design from SARS-CoV-2 spike glycoprotein. Vaccines., 11, 399.","journal-title":"Vaccines."},{"key":"1358_CR45","doi-asserted-by":"publisher","first-page":"19087","DOI":"10.1038\/s41598-022-23550-w","volume":"12","author":"S Zaib","year":"2022","unstructured":"Zaib, S., Akram, F., Liaqat, S. T., Altaf, M. Z., Khan, I., Dera, A. A., Uddin, J., Khan, A., & Al-Harrasi, A. (2022). Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2. Science and Reports, 12, 19087.","journal-title":"Science and Reports"},{"key":"1358_CR46","first-page":"359","volume":"12","author":"Y Ysrafil","year":"2022","unstructured":"Ysrafil, Y., & Sapiun, Z. (2022). Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach. BioImpacts: BI, 12, 359\u2013370.","journal-title":"BioImpacts: BI"},{"key":"1358_CR47","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1038\/s41598-021-81749-9","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang, Z., Bogdan, P., & Nazarian, S. (2021). An in silico deep learning approach to multi-epitope vaccine design: A SARS-CoV-2 case study. Science and Reports, 11, 3238.","journal-title":"Science and Reports"},{"key":"1358_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijcs.12695","volume":"45","author":"J Paul","year":"2021","unstructured":"Paul, J., Lim, W. M., O\u2019Cass, A., Hao, A., & Bresciani, S. (2021). Scientific procedures and rationales for systematic literature reviews (SPAR-4-SLR). International Journal of Consumer Studies, 45, 1\u201316.","journal-title":"International Journal of Consumer Studies"},{"key":"1358_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4018\/979-8-3693-1475-3.ch006","volume-title":"Financial inclusion, sustainability, and the influence of religion and technology","author":"F Ahmad","year":"2024","unstructured":"Ahmad, F., Cheong, C. W., Hussain, R. T., Salman, A., Hussain, K., Shahid, M. K., & Naseem, M. A. (2024). Financial inclusion and sustainability: A contemporary and future perspective from bibliometric analysis. Financial inclusion, sustainability, and the influence of religion and technology (pp. 105\u2013132). IGI Global."},{"key":"1358_CR50","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1007\/s11192-021-03948-5","volume":"126","author":"VK Singh","year":"2021","unstructured":"Singh, V. K., Singh, P., Karmakar, M., Leta, J., & Mayr, P. (2021). The journal coverage of web of science, Scopus and Dimensions: A comparative analysis. Scientometrics, 126, 5113\u20135142.","journal-title":"Scientometrics"},{"key":"1358_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1162\/qss_a_00019","volume":"1","author":"J Baas","year":"2020","unstructured":"Baas, J., Schotten, M., Plume, A., C\u00f4t\u00e9, G., & Karimi, R. (2020). Scopus as a curated, high-quality bibliometric data source for academic research in quantitative science studies. Quant Sci Stud., 1, 377\u2013386.","journal-title":"Quant Sci Stud."},{"key":"1358_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248371","volume":"16","author":"M Umair","year":"2021","unstructured":"Umair, M., Ikram, A., Salman, M., Khurshid, A., Alam, M., Badar, N., Suleman, R., Tahir, F., Sharif, S., & Montgomery, J. (2021). Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan. PLoS ONE, 16, e0248371.","journal-title":"PLoS ONE"},{"key":"1358_CR53","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.1038\/s41598-020-67749-1","volume":"10","author":"T Kar","year":"2020","unstructured":"Kar, T., Narsaria, U., Basak, S., Deb, D., Castiglione, F., Mueller, D. M., & Srivastava, A. P. (2020). A candidate multi-epitope vaccine against SARS-CoV-2. Science and Reports, 10, 10895.","journal-title":"Science and Reports"},{"key":"1358_CR54","first-page":"2857","volume":"39","author":"M Enayatkhani","year":"2021","unstructured":"Enayatkhani, M., Hasaniazad, M., & Faezi, S. (2021). Contriving multi-epitope subunit of vaccine for COVID-19: Immunoinformatics approaches. Frontiers in Immunology, 39, 2857\u20132872.","journal-title":"Frontiers in Immunology"},{"key":"1358_CR55","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3389\/fimmu.2020.01784","volume":"11","author":"R Dong","year":"2020","unstructured":"Dong, R., Chu, Z., Yu, F., & Zha, Y. (2020). Contriving multi-epitope subunit of vaccine for COVID-19: Immunoinformatics approaches. Frontiers in Immunology, 11, 1784.","journal-title":"Frontiers in Immunology"},{"key":"1358_CR56","doi-asserted-by":"publisher","first-page":"e9572","DOI":"10.7717\/peerj.9572","volume":"8","author":"MS Rahman","year":"2020","unstructured":"Rahman, M. S., Hoque, M. N., Islam, M. R., Akter, S., Rubayet Ul Alam, A. S. M., Siddique, M. A., Saha, O., Rahaman, M. M., Sultana, M., Crandall, K. A., & Hossain, M. A. (2020). Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: An in silico approach. PeerJ, 8, e9572.","journal-title":"PeerJ"},{"key":"1358_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/07391102.2020.1792347","volume":"40","author":"A Samad","year":"2022","unstructured":"Samad, A., Ahammad, F., Nain, Z., Alam, R., Imon, R. R., Hasan, M., & Rahman, M. S. (2022). Designing a multi-epitope vaccine against SARS-CoV-2: An immunoinformatics approach. Journal of Biomolecular Structure & Dynamics, 40, 14\u201330.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1358_CR58","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1080\/07391102.2020.1770127","volume":"39","author":"K Abraham Peele","year":"2021","unstructured":"Abraham Peele, K., Srihansa, T., & Krupanidhi, S. (2021). Design of multi-epitope vaccine candidate against SARS-CoV-2: A in-silico study. Journal of Biomolecular Structure & Dynamics, 39, 3793\u20133801.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1358_CR59","doi-asserted-by":"crossref","unstructured":"Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38, 7612\u20137628.","DOI":"10.1016\/j.vaccine.2020.10.016"},{"key":"1358_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40249-020-00752-w","volume":"9","author":"M Tahir Ul Qamar","year":"2020","unstructured":"Tahir Ul Qamar, M., Shahid, F., Aslam, S., Ashfaq, U. A., Aslam, S., Fatima, I., Fareed, M. M., Zohaib, A., & Chen, L. L. (2020). Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infectious Diseases of Poverty, 9, 132.","journal-title":"Infectious Diseases of Poverty"},{"key":"1358_CR61","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3389\/fimmu.2020.01663","volume":"11","author":"A Naz","year":"2020","unstructured":"Naz, A., Shahid, F., Butt, T. T., Awan, F. M., Ali, A., & Malik, A. (2020). Designing multi-epitope vaccines to combat emerging coronavirus disease 2019 (COVID-19) by employing immuno-informatics approach. Frontiers in Immunology, 11, 1663.","journal-title":"Frontiers in Immunology"},{"key":"1358_CR62","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1038\/s41598-021-91997-4","volume":"11","author":"S Sanami","year":"2021","unstructured":"Sanami, S., Azadegan-Dehkordi, F., Rafieian-Kopaei, M., Salehi, M., Ghasemi-Dehnoo, M., Mahooti, M., Alizadeh, M., & Bagheri, N. (2021). Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches. Science and Reports, 11, 12397.","journal-title":"Science and Reports"},{"key":"1358_CR63","doi-asserted-by":"publisher","first-page":"bbac567","DOI":"10.1093\/bib\/bbac567","volume":"24","author":"G Cia","year":"2023","unstructured":"Cia, G., Pucci, F., & Rooman, M. (2023). Critical review of conformational B-cell epitope prediction methods. Briefings in Bioinformatics, 24, bbac567.","journal-title":"Briefings in Bioinformatics"},{"key":"1358_CR64","doi-asserted-by":"crossref","unstructured":"Galanis, K. A., Nastou, K. C., Papandreou, N. C., Petichakis, G. N., Pigis, D. G., & Iconomidou, V. A. (2021). Linear B-cell epitope prediction for vaccine design: A performance review of methods available via command-line interface. International Journal of Molecular Sciences, 22(6), 3210.","DOI":"10.3390\/ijms22063210"},{"key":"1358_CR65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/bioinformatics\/btaa773","volume":"37","author":"M Collatz","year":"2020","unstructured":"Collatz, M., Mock, F., Barth, E., H\u00f6lzer, M., Sachse, K., & Marz, M. (2020). EpiDope: A deep neural network for linear B-cell epitope prediction. Bioinformatics, 37, 448\u2013455.","journal-title":"Bioinformatics"},{"key":"1358_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-immunol-082119-124838","volume":"38","author":"B Peters","year":"2020","unstructured":"Peters, B., Nielsen, M., & Sette, A. (2020). T cell epitope predictions. Annual Review of Immunology, 38, 123\u2013145.","journal-title":"Annual Review of Immunology"},{"key":"1358_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodcont.2020.107178","volume":"113","author":"LN Shwaiki","year":"2020","unstructured":"Shwaiki, L. N., Arendt, E. K., & Lynch, K. M. (2020). Anti-yeast activity and characterisation of synthetic radish peptides Rs-AFP1 and Rs-AFP2 against food spoilage yeast. Food Control, 113, 107178.","journal-title":"Food Control"},{"key":"1358_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682001","volume":"12","author":"G Lozano Terol","year":"2021","unstructured":"Lozano Terol, G., Gallego-Jara, J., Sola Martinez, R. A., Martinez Vivancos, A., C\u00e1novas D\u00edaz, M., & de Diego Puente, T. (2021). Impact of the expression system on recombinant protein production in Escherichia coli BL21. Frontiers in Microbiology, 12, 682001.","journal-title":"Frontiers in Microbiology"},{"key":"1358_CR69","doi-asserted-by":"publisher","first-page":"108121","DOI":"10.1016\/j.biotechadv.2023.108121","volume":"64","author":"P De Brabander","year":"2023","unstructured":"De Brabander, P., Uitterhaegen, E., Delmulle, T., De Winter, K., & Soetaert, W. (2023). Challenges and progress towards industrial recombinant protein production in yeasts: A review. Biotechnology Advances, 64, 108121.","journal-title":"Biotechnology Advances"},{"key":"1358_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10529-019-02755-6","volume":"42","author":"Z Qu","year":"2020","unstructured":"Qu, Z., Li, M., Guo, Y., Liu, Y., Wang, J., & Gao, M. (2020). Biotechnology letters, 42, 57\u201365.","journal-title":"Biotechnology letters"},{"key":"1358_CR71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","volume":"5","author":"GL Rosano","year":"2014","unstructured":"Rosano, G. L., & Ceccarelli, E. A. (2014). Recombinant protein expression in Escherichia coli: Advances and challenges. Frontiers in Microbiology, 5, 172.","journal-title":"Frontiers in Microbiology"},{"key":"1358_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.122627","volume":"1172","author":"B Sakhel","year":"2021","unstructured":"Sakhel, B., Jayanthi, S., Muhoza, D., Okoto, P., Kumar, T. K. S., & Adams, P. (2021). Simplification of the purification of heat stable recombinant low molecular weight proteins and peptides from GST-fusion products. Journal of Chromatography B, 1172, 122627.","journal-title":"Journal of Chromatography B"},{"key":"1358_CR73","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/separations9070164","volume":"9","author":"J Ju\u00e1rez-Lucero","year":"2022","unstructured":"Ju\u00e1rez-Lucero, J., Guevara-Villa, M. D. R., S\u00e1nchez-S\u00e1nchez, A., D\u00edaz-Hern\u00e1ndez, R., & Altamirano-Robles, L. (2022). Development of a methodology to adapt an equilibrium buffer\/wash applied to the purification of hGPN2 protein expressed in Escherichia coli using an IMAC immobilized metal affinity chromatography System. Separations, 9, 164.","journal-title":"Separations"},{"key":"1358_CR74","first-page":"173","volume-title":"Textbook on Cloning","author":"A Chakraborty","year":"2022","unstructured":"Chakraborty, A., Puja, R., & Bose, K. (2022). Protein purification by ion exchange chromatography. Textbook on Cloning (pp. 173\u2013198). Expression and Purification of Recombinant Proteins."},{"key":"1358_CR75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12934-022-01778-5","volume":"21","author":"K Remans","year":"2022","unstructured":"Remans, K., Lebendiker, M., Abreu, C., Maffei, M., Sellathurai, S., May, M. M., Van\u011bk, O., & De Marco, A. (2022). Protein purification strategies must consider downstream applications and individual biological characteristics. Microbial Cell Factories, 21, 52.","journal-title":"Microbial Cell Factories"},{"key":"1358_CR76","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-1-0716-3362-5_17","volume-title":"Protein Chromatography: Methods and Protocols","author":"BJ Ryan","year":"2023","unstructured":"Ryan, B. J., Kinsella, G. K., & Henehan, G. T. (2023). Protein extraction and purification by differential solubilization. Protein Chromatography: Methods and Protocols (pp. 349\u2013368). Springer."},{"key":"1358_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2020.108894","volume":"251","author":"P Gu","year":"2020","unstructured":"Gu, P., Wusiman, A., Zhang, Y., Cai, G., Xu, S., Zhu, S., Liu, Z., Hu, Y., Liu, J., & Wang, D. (2020). Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants. Veterinary Microbiology, 251, 108894.","journal-title":"Veterinary Microbiology"},{"key":"1358_CR78","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bj.2020.09.005","volume":"44","author":"HX Lim","year":"2021","unstructured":"Lim, H. X., Lim, J., Jazayeri, S. D., Poppema, S., & Poh, C. L. (2021). Development of multi-epitope peptide-based vaccines against SARS-CoV-2. Biomedical Journal, 44, 18\u201330.","journal-title":"Biomedical Journal"},{"key":"1358_CR79","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/vaccines10111906","volume":"10","author":"X Gong","year":"2022","unstructured":"Gong, X., Gao, Y., Shu, J., Zhang, C., & Zhao, K. (2022). Chitosan-based nanomaterial as immune adjuvant and delivery carrier for vaccines. Vaccines., 10, 1906.","journal-title":"Vaccines."},{"key":"1358_CR80","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1111\/cts.13387","volume":"15","author":"N Steeghs","year":"2022","unstructured":"Steeghs, N., Hansen, A. R., Hanna, G. J., Garralda, E., Park, H., Strauss, J., Adam, M., Campbell, G., Carver, J., Easton, R., Mays, K., Skrdla, P., Struemper, H., Washburn, M. L., Matheny, C., & Piha-Paul, S. A. (2022). Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development. Clinical and Translational Science, 15, 2625\u20132639.","journal-title":"Clinical and Translational Science"},{"key":"1358_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007390","volume":"14","author":"J Olejnik","year":"2018","unstructured":"Olejnik, J., Hume, A. J., & M\u00fchlberger, E. (2018). Toll-like receptor 4 in acute viral infection: Too much of a good thing. PLoS Pathogens, 14, e1007390.","journal-title":"PLoS Pathogens"},{"key":"1358_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104970","volume":"157","author":"E Jafari","year":"2021","unstructured":"Jafari, E., & Mahmoodi, S. (2021). Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant. Microbial Pathogenesis, 157, 104970.","journal-title":"Microbial Pathogenesis"},{"key":"1358_CR83","first-page":"2204184","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Fan, Z., Liu, J., Wang, J., Xu, M., Li, X., Xu, Y., Lu, Y., Han, C., & Zhang, Z. (2023). Melittin-carrying nanoparticle suppress T cell-driven immunity in a murine allergic dermatitis model. Advancement of Science, 10, 2204184.","journal-title":"Advancement of Science"},{"key":"1358_CR84","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10096-019-03674-0","volume":"39","author":"H Memariani","year":"2020","unstructured":"Memariani, H., Memariani, M., Moravvej, H., & Shahidi-Dadras, M. (2020). Melittin: A venom-derived peptide with promising anti-viral properties. European Journal of Clinical Microbiology and Infectious Diseases, 39, 5\u201317.","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"1358_CR85","doi-asserted-by":"publisher","first-page":"9607","DOI":"10.1038\/s41598-023-36397-6","volume":"13","author":"T Ishii","year":"2023","unstructured":"Ishii, T., Hamada, K., Jubishi, D., Hashimoto, H., Okamoto, K., Hisasue, N., Sunohara, M., Saito, M., Shinohara, T., Yamashita, M., Wakimoto, Y., Otani, A., Ikeda, M., Harada, S., Okugawa, S., Moriya, K., & Yanagimoto, S. (2023). Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination. Science and Reports, 13, 9607.","journal-title":"Science and Reports"},{"key":"1358_CR86","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41467-022-28527-x","volume":"13","author":"H Ward","year":"2022","unstructured":"Ward, H., Whitaker, M., Flower, B., Tang, S. N., Atchison, C., Darzi, A., Donnelly, C. A., Cann, A., Diggle, P. J., & Ashby, D. (2022). Population antibody responses following COVID-19 vaccination in 212,102 individuals. Nature Communications, 13, 907.","journal-title":"Nature Communications"},{"key":"1358_CR87","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3390\/vaccines11071196","volume":"11","author":"MK Verheul","year":"2023","unstructured":"Verheul, M. K., Nijhof, K. H., de Zeeuw-Brouwer, M. L., Duijm, G., Ten Hulscher, H., de Rond, L., Beckers, L., Eggink, D., van Tol, S., Reimerink, J., Boer, M., & van Beek, J. (2023). Booster immunization improves memory B cell responses in older adults unresponsive to primary SARS-CoV-2 immunization. Vaccines., 11, 1196.","journal-title":"Vaccines."},{"key":"1358_CR88","unstructured":"Guirakhoo, F., Kuo, L., Peng, J., Huang, J.-H., Kuo, B.-S., Lin, F., Liu, Y.-J., Liu, Z., Wu, G., Ding, S., Hou, K.-L., Cheng, J., Yang, V., Jiang, H., Wang, J., Chen, T., Xia, W., Lin, E., Hung, C. H., Chen, H.-J., Shih, Z., Lin, Y.-L., Wang, S., Ryan, V., Schurter, B. T., Hu, M. M., Heppner, G., Malherbe, D. C., Bukreyev, A., Hellerstein, M., Monath, T. P. and Wang, C. Y. (2021) bioRxiv : the preprint server for biology."},{"key":"1358_CR89","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/vaccines11050998","volume":"11","author":"AB Ryzhikov","year":"2023","unstructured":"Ryzhikov, A. B., Ryzhikov, E. A., Bogryantseva, M. P., Usova, S. V., Nechaeva, E. A., Danilenko, E. D., Pyankov, S. A., & Gudymo, A. S. (2023). Assessment of safety and prophylactic efficacy of the EpiVacCorona peptide vaccine for COVID-19 prevention (Phase III). Vaccines., 11, 998.","journal-title":"Vaccines."},{"key":"1358_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102572","volume":"4","author":"A Sch\u00fctz","year":"2023","unstructured":"Sch\u00fctz, A., Bernhard, F., Berrow, N., Buyel, J. F., Ferreira-da-Silva, F., Haustraete, J., van den Heuvel, J., Hoffmann, J.-E., de Marco, A., Peleg, Y., Suppmann, S., Unger, T., Vanhoucke, M., Witt, S., & Remans, K. (2023). A concise guide to choosing suitable gene expression systems for recombinant protein production. STAR Protocols., 4, 102572.","journal-title":"STAR Protocols."},{"key":"1358_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/bmjebm-2018-111107","volume":"24","author":"NJ DeVito","year":"2019","unstructured":"DeVito, N. J., & Goldacre, B. (2019). BMJ Evidence-Based Medicine, 24, 53\u201354.","journal-title":"BMJ Evidence-Based Medicine"},{"key":"1358_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2020.103802","volume":"108","author":"AS Tungate","year":"2021","unstructured":"Tungate, A. S., & Conners, F. A. (2021). Executive function in Down syndrome: A meta-analysis. Research in Developmental Disabilities, 108, 103802.","journal-title":"Research in Developmental Disabilities"},{"key":"1358_CR93","first-page":"60","volume":"25","author":"K Khalid","year":"2024","unstructured":"Khalid, K., Lim, H. X., Anwar, A., Tan, S. H., Hwang, J. S., Ong, S. K., & Poh, C. L. (2024). Preclinical development of a novel epitope-based DNA vaccine candidate against SARS-CoV-2 and evaluation of immunogenicity in BALB\/c mice. An Official Journal of the American Association of Pharmaceutical Scientists, 25, 60.","journal-title":"An Official Journal of the American Association of Pharmaceutical Scientists"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01358-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01358-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01358-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:14:41Z","timestamp":1769231681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01358-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01358-5","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}